Consolidated Entity Disclosure Statement For the Year Ended 30 June 2026 The ultimate controlling entity of the CSL Group is CSL Limited, otherwise described as the parent company. Outlined below is the Group’s consolidated entity disclosure statement as at 30 June 2026 prepared in accordance with the Corporations Act 2001 (Cth). Unless otherwise indicated, no entities are trustees, partners or participants in joint ventures. Entity name (all represent body corporate entities unless otherwise specified) Australian or Foreign resident Country of Incorporation and Tax Residency7 Percentage owned (%) CSL Limited Australian Australia Controlled entities (wholly owned) of CSL Limited: CSL Employee Share Trust Australian Australia n/a8 CSL Gene Therapy Pty Ltd Australian Australia 100 % CSL Innovation Pty Ltd Australian Australia 100 % CSL Behring (Australia) Pty Ltd Australian Australia 100 % CSL Behring (Holdings) Pty Ltd Australian Australia 100 % CSL Finance Pty Ltd Australian Australia 100 % CSL IP Investments Pty Ltd Australian Australia 100 % Seqirus (Australia) Pty Ltd Australian Australia 100 % Seqirus Holdings Australia Pty Ltd Australian Australia 100 % Seqirus Pty Ltd Australian Australia 100 % CSL Behring GmbH Foreign Austria 100 % Vifor Pharma Österreich GmbH Foreign Austria 100 % CSL Behring S.A. Foreign Argentina 100 % Laboratorios Seqirus S.A. Foreign Argentina 100 % Vifor Pharma América Latina S.A. Foreign Argentina 100 % CSL Behring NV Foreign Belgium 100 % Vifor Pharma België NV Foreign Belgium 100 % CSL Behring Comercio de Produtos Farmaceuticos Ltda Foreign Brazil 100 % Seqirus Laboratorios Do Brasil Ltda Foreign Brazil 100 % Vifor Pharma Brasil Ltda. Foreign Brazil 100 % CSL Behring Canada Inc Foreign Canada 100 % Vitaeris Inc Foreign Canada 100 % Seqirus Canada Inc Foreign Canada 100 % CSL Behring SpA Foreign Chile 100 % Guangzhou Junxin Pharmaceutical Co Ltd Foreign China 100 % CSL Behring Colombia S.A.S Foreign Colombia 100 % 3-101-951959 Sociedad Anonima Foreign Costa Rica 100 % CSL Behring s.r.o. Foreign Czech Republic 100 % CSL Behring ApS Foreign Denmark 100 % CSL Behring S.A. Foreign France 100 % Vifor France S.A.S. Foreign France 100 % Seqirus France S.A.S. Foreign France 100 % CSL France S.A.S. Foreign France 100 % CSL Behring GmbH Foreign Germany 100 % Consolidated Entity Disclosure Statement 133 For the Year Ended 30 June 2026 7 All entities have retained the same tax residency as their country of incorporation. 8 CSL Employee Share Trust is a trust and therefore does not have an ownership interest 133 CSL Limited Annual Report 2025/26
RkJQdWJsaXNoZXIy MjE2NDg3